ResMed(RMD) - 2022 Q2 - Earnings Call Transcript

ResMed Inc. (NYSE:RMD) Q2 2022 Earnings Conference Call January 27, 2021 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Mick Farrell - CEO Brett Sandercock - CFO Rob Douglas - President and COO Jim Hollingshead - President, Sleep & Respiratory Care business David Pendarvis - Chief Administrative Officer and Global General Counsel Conference Call Participants Chris Cooper - Goldman Sachs Dan Hurren - MST Marquee Sean Laaman - Morgan Stanley Matthew Mishan - KeyBanc Craig Wong ...